Export 2757 results:
Author [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
M. S. de Souza, Ratto-Kim, S., Chuenarom, W., Schuetz, A., Chantakulkij, S., Nuntapinit, B., Valencia-Micolta, A., Thelian, D., Nitayaphan, S., Pitisuttithum, P., Paris, R. M., Kaewkungwal, J., Michael, N. L., Rerks-Ngarm, S., Mathieson, B., Marovich, M., Currier, J. R., and Kim, J. H., “The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.”, J Immunol, vol. 188, no. 10, pp. 5166-76, 2012.
J. M. Jumper, Scott, I. U., Van Veldhuisen, P., Oden, N., Ip, M., Blodi, B., Figueroa, M., and Group, S. C. O. R. E. Study Inve, “Testing versus Hochberg's Method for Strongly Controlling Family-Wide Type I Error When Making All Pairwise Comparisons of Means in the SCORE Study”, in Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale FL, 2008.
Z. Wu, Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., Lindblad, R., Gu, D., Tang, H., Hu, L., Zhu, Q., Lu, L., Oden, N., Hasson, A. L., Zhao, Y., McGoogan, J. M., Ge, X., Zhang, N., Rou, K., Zhu, J., Wei, H., Shi, C. X., Jin, X., Li, J., and Montaner, J. S. G., “Testing and linkage to HIV care in China: a cluster-randomised trial.”, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
E. Koo, Chang, J. R., Agrón, E., Clemons, T. E., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33.”, Ophthalmic Epidemiol, vol. 20, no. 2, pp. 71-81, 2013.
E. Koo, Chang, J., E, A., Clemons, T. E., Sperduto, R. D., 3rd, F. L. Ferris, Chew, E. Y., and AREDS), T. Age- Relate, “Ten-year Incidence Rates of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 33”, Ophthalmic Epidemiology, vol. 20, pp. 71-81, 2013.
E. Y. Chew, Clemons, T. E., Agrón, E., Sperduto, R. D., Sangiovanni, J. Paul, Davis, M. D., and Ferris, F. L., “Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
E. Y. Chew, Clemons, T. E., Agron, E., Sperduto, R. D., SanGiovanni, J. P., Davis, M. D., 3rd, F. L. Ferris, and AREDS), T. Age- Relate, “Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36”, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
M. Roland, Barin, B., Blumberg, E., Feinberg, J., Fox, L., Huprikar, S., Wong, M., Diego, J., Simon, D., and Stock, P., “Tenofovir is not associated with renal dysfunction following solid organ transplantation”, presented at the 2011, Philadelphia, PA, 2011.
“Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS”, presented at the 05Nov2020, 2020.
J. B. Goll, Jensen, T. L., R. Lindsley, C., Bejar, R., Walker, J., Fulton, R., Abel, G. A., Baghdadi, T. Al, H. Deeg, J., DeZern, A. E., Ebert, B. L., Foran, J. M., Gorak, E. J., Gore, S. D., Komrokji, R., Liu, J. Jijun, Maciejewski, J. P., Padron, E., Saber, W., Starczynowski, D., Waclawiw, M., Wilson, S. H., Hebert, D., Reed, H., DiFronzo, N. L., Sekeres, M. A., Harrington, A. M., Kroft, S. H., and Zhang, L., “Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS”, Blood, vol. 136, no. Supplement 1, pp. 32-33, 2020.
N. Oden and Sharma, G., “Tangency Outcomes for Clinical Trials”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W., Pasquini, M., MacMillan, M., Wingard, J., Waller, E., Grupp, S., McCarthy, P., Wu, J., Hu, Z., Carter, S., Horowitz, M. M., and Antin, J. H., “Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. - H., Carter, S. L., Horowitz, M. M., and Antin, J. H., “Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.”, Blood, vol. 124, no. 8, pp. 1372-7, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., “Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT”, Blood, vol. 124, pp. 1372-1377, 2014.
J. A. Kobashigawa, Miller, L. W., Russell, S. D., Ewald, G. A., Zucker, M. J., Goldberg, L. R., Eisen, H. J., Salm, K., Tolzman, D., Gao, J., Fitzsimmons, W., and First, R., “Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.”, Am J Transplant, vol. 6, no. 6, pp. 1377-86, 2006.
J. Kobashigawa, Miller, L., Russell, S., Ewald, G., Zucker, M., Goldberg, L., Eisen, H., Salm, K., Tolzman, D., Gao, J., Fitzsimmons, W., First, M., and Investigators, S., “Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report”, Am J Transplant, vol. 6, pp. 1377-1386, 2006.
A. M. Neu, Ho, P. L., Furth, S. L., Fine, R. N., and Fivush, B. A., “Tacrolimus vs. Cyclosporine as primary immunosuppression in pediatric renal transplant patients: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report”, 2001.
A. M. Neu, Ho, M., Furth, S. L., Fine, R. N., and Fivush, B. A., “Tacrolimus vs. Cyclosporine as Primary Immunosuppression in Pediatric Renal Transplant Patients: a naprtcs study”, 2002.
A. M. Neu, Ho, P. L. Martin, Fine, R. N., Furth, S. L., and Fivush, B. A., “Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.”, Pediatr Transplant, vol. 7, no. 3, pp. 217-22, 2003.
A. M. Neu, Ho, P. L., Fine, R. N., Furth, S. L., and Fivush, B. A., “Tacrolimus vs cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study”, Pediatric Transplantation, vol. 7, pp. 217-222, 2003.
G. W. Burke, Kaufman, D. B., Bruce, D. S., Sutherland, D., Johnson, C. P., Gaber, A. O., Merion, R. M., Schweitzer, E., Marsh, C. L., Gruber, S. A., Alfrey, E., Leone, J. P., Conception, W., Stegall, M. D., Gores, P. S., Danovitch, G., Nunnally, P. J., Henning, A. K., and Fitzsimmons, W. E., “Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results”, 2001.
M. Lebwohl, Freeman, A. Krupnick, M Chapman, S., Feldman, S. R., Hartle, J. E., and Henning, A., “Tacrolimus ointment is effective for facial and intertriginous psoriasis.”, J Am Acad Dermatol, vol. 51, no. 5, pp. 723-30, 2004.
M. Lebwohl, Freeman, A. K., Chapman, M. S., ,, J Hartle, M. P. H., Henning, A. K., and Group, T. Ointment S., “Tacrolimus Ointment is Effective for Facial and Intertriginous Psoriasis”, Journal of the American Academy of Dermatology, vol. 51, pp. 723-30, 2004.
A. Krupnick Freeman, Linowski, G. J., Brady, C., Lind, L., VanVeldhuisen, P., Singer, G., and Lebwohl, M., “Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas.”, J Am Acad Dermatol, vol. 48, no. 4, pp. 564-8, 2003.
A. K. Freeman, Linowski, G. C., Brady, C., Lind, L., Van Veldhuisen, P., Singer, G., and Lebwohl, M., “Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas”, J Amer Acad Dermatology, vol. 48, pp. 564-8, 2003.